- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 14/15 - Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
Patent holdings for IPC class C07K 14/15
Total number of patents in this class: 162
10-year publication summary
5
|
3
|
5
|
13
|
9
|
15
|
10
|
6
|
8
|
2
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Institut National de La Sante et de La Recherche Medicale (inserm) | 2360 |
9 |
Variation Biotechnologies, Inc. | 75 |
7 |
Centre National de La Recherche Scientifique | 9632 |
6 |
The Regents of the University of California | 18943 |
4 |
Universite Claude Bernard Lyon 1 | 921 |
4 |
Autolus Limited | 232 |
3 |
Centre Leon Berard | 149 |
3 |
Ecole Normale Superieure de Lyon | 220 |
3 |
Institut Pasteur | 798 |
3 |
University of Washington | 2157 |
3 |
Lentigen Technology, Inc. | 91 |
3 |
California Institute of Technology | 3884 |
2 |
Duke University | 2872 |
2 |
Codexis, Inc. | 776 |
2 |
Commonwealth Scientific and Industrial Research Organisation | 1652 |
2 |
Grains Research and Development Corporation | 90 |
2 |
Janssen Biotech, Inc. | 1347 |
2 |
Los Alamos National Security, LLC | 312 |
2 |
Merial, Inc. | 236 |
2 |
Protagonist Therapeutics, Inc. | 124 |
2 |
Other owners | 96 |